Cargando…

Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies

NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmowafy, Mohammed, Al-Sanea, Mohammad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463508/
https://www.ncbi.nlm.nih.gov/pubmed/34588846
http://dx.doi.org/10.1016/j.jsps.2021.07.015
_version_ 1784572411246542848
author Elmowafy, Mohammed
Al-Sanea, Mohammad M.
author_facet Elmowafy, Mohammed
Al-Sanea, Mohammad M.
author_sort Elmowafy, Mohammed
collection PubMed
description NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers’ formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future.
format Online
Article
Text
id pubmed-8463508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84635082021-09-28 Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies Elmowafy, Mohammed Al-Sanea, Mohammad M. Saudi Pharm J Review NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers’ formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future. Elsevier 2021-09 2021-07-21 /pmc/articles/PMC8463508/ /pubmed/34588846 http://dx.doi.org/10.1016/j.jsps.2021.07.015 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Elmowafy, Mohammed
Al-Sanea, Mohammad M.
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title_full Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title_fullStr Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title_full_unstemmed Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title_short Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
title_sort nanostructured lipid carriers (nlcs) as drug delivery platform: advances in formulation and delivery strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463508/
https://www.ncbi.nlm.nih.gov/pubmed/34588846
http://dx.doi.org/10.1016/j.jsps.2021.07.015
work_keys_str_mv AT elmowafymohammed nanostructuredlipidcarriersnlcsasdrugdeliveryplatformadvancesinformulationanddeliverystrategies
AT alsaneamohammadm nanostructuredlipidcarriersnlcsasdrugdeliveryplatformadvancesinformulationanddeliverystrategies